Patient Access

Spero Health will widen its use of Pear's reSET and reSET-O prescription digital therapeutics from 14 clinics in Kentucky to 99 locations in five other states.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

The company seeks to meet the rising demand for specialised care across Southeast Asia.

The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.

MediOrbis will incorporate Kahun's AI tool into its platform to provide clinical insights to healthcare providers based on patients’ intake information.   

The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.

However, these tools are not yet able to provide personalised advice.

Telemedicine use has declined since the height of the COVID-19 pandemic. Providers can rethink how they use telehealth to get the most out of the modality and improve care.

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.

Sanjula Jain, senior vice president of market strategy and chief research officer at Trilliant Health, discusses the future of virtual care and how emerging retail players will affect the industry.